A Study of Patients With AIDS Syndrome
Oncogenic Viral Pathogenesis and Cancer Risk Factors Among Patients With the Acquired Immunodeficiency Syndrome: A Prospective Cohort Study
1 other identifier
observational
5,000
1 country
23
Brief Summary
The purpose of this study is to find out why cancers develop in HIV-positive patients. Cancer is a leading cause of death in AIDS patients. Common cancers in HIV-infected patients include Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL), a cancer of the immune system. Risk factors include certain chemicals, viruses, and perhaps even anti-HIV drugs. Doctors would like to find out which risk factors are most important and how they relate to cancer in AIDS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
23 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 1999
CompletedFirst Posted
Study publicly available on registry
August 31, 2001
CompletedSeptember 12, 2008
May 1, 2006
November 2, 1999
September 11, 2008
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- You may be eligible for this trial if you:
- Are HIV-positive.
- Have a CD4+ cell count of 200 cells/mm3 or below.
- Are 18 years of age or older.
You may not qualify if:
- You will not be eligible for this trial if you:
- Are not available for follow-up for at least 3 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (23)
Willow Clinic
Menlo Park, California, 94025, United States
San Francisco Gen Hosp
San Francisco, California, 941102859, United States
Marin County Specialty Clinic
San Rafael, California, 94903, United States
San Mateo AIDS Program / Stanford Univ
Stanford, California, 943055107, United States
Stanford Univ Med Ctr
Stanford, California, 943055107, United States
Univ of Hawaii
Honolulu, Hawaii, 96816, United States
Indiana Univ Hosp
Indianapolis, Indiana, 462025250, United States
Charity Hosp / Tulane Univ Med School
New Orleans, Louisiana, 70112, United States
Tulane Univ School of Medicine
New Orleans, Louisiana, 70112, United States
Johns Hopkins Hosp
Baltimore, Maryland, 21287, United States
Harvard (Massachusetts Gen Hosp)
Boston, Massachusetts, 02114, United States
SUNY / Erie County Med Ctr at Buffalo
Buffalo, New York, 14215, United States
Bellevue Hosp / New York Univ Med Ctr
New York, New York, 10016, United States
Mem Sloan - Kettering Cancer Ctr
New York, New York, 10021, United States
St Mary's Hosp (Univ of Rochester/Infectious Diseases)
Rochester, New York, 14642, United States
Univ of Rochester Medical Center
Rochester, New York, 14642, United States
Univ of North Carolina
Chapel Hill, North Carolina, 275997215, United States
Duke Univ Med Ctr
Durham, North Carolina, 27710, United States
Univ of Cincinnati
Cincinnati, Ohio, 452670405, United States
Case Western Reserve Univ
Cleveland, Ohio, 44106, United States
MetroHealth Med Ctr
Cleveland, Ohio, 441091998, United States
Ohio State Univ Hosp Clinic
Columbus, Ohio, 432101228, United States
Univ of Washington
Seattle, Washington, 98104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
David A. Wohl
Univ of North Carolina
- STUDY CHAIR
Ann C. Collier
Univ of Washington
- STUDY CHAIR
William G. Powderly
- PRINCIPAL INVESTIGATOR
Charles S. Rabkin
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
November 2, 1999
First Posted
August 31, 2001
Last Updated
September 12, 2008
Record last verified: 2006-05